Specifically, circGSK3β positively regulates PRMT5 expression via miR-338-3p, thereby facilitating the recruitment of H3K4me3 to the PD-L1 promoter, ultimately fostering immune escape and tumor progression in BC. Here, CD274 is linked to breast cancer.